About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Ten satellites, each around the size of a shoebox, are slated in a few years to enter orbit and begin filling in some gaping holes in our understanding of clouds and their role in climate. Inspired by medical CT (computed tomography), which observes and maps patients’ interiors, the designers are creating a system that will reveal detailed images of clouds’ external and internal 3D structures and properties. By probing small cloud fields that are generally missed by today’s remote-sensing technologies, the mission may resolve some major uncertainties that limit current atmospheric modelling and climate prediction.
December 17, 2018
According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime. In a study published in Cell Reports, researchers at the Weizmann Institute of Science have revealed a previously unknown mechanism underlying anxiety. Targeting this biochemical pathway may help develop new therapies to alleviate the symptoms of anxiety disorders.
December 11, 2018
In an effort to advance basic research insights for the benefit of therapeutic discoveries, the Weizmann Institute of Science is establishing the Dr. Barry Sherman Institute for Medicinal Chemistry, thanks to a major gift from the Sherman family.
December 10, 2018
Cancer arises when cells lose control. Deciphering the “blueprint” of cancer cells – outlining how cancer cells hijack specific pathways for uncontrolled proliferation – will lead to more efficient ways to fight it. Now, in a joint effort, scientists from the Weizmann Institute of Science and clinicians from major hemato-oncology departments in Israel have successfully created detailed profiles of myeloma cancer in both pre-cancer stages, in newly diagnosed multiple myeloma patients, as well as post-treatment and relapse. These detailed blueprints will help in future precision diagnosis and treatment of this disease.
December 06, 2018
At its 70th annual International Board Meeting, the Weizmann Institute of Science conferred the degree of Doctor of Philosophy honoris causa upon longtime supporter and leader Ellen Merlo. The Weizmann Institute of Science, located in Rehovot, Israel, is one of the world’s leading centers of multidisciplinary scientific research.
December 04, 2018
The Executive Board of the Weizmann Institute of Science, headed by Shimshon Harel, announced that they have elected Prof. Alon Chen to be the 11th president of the Weizmann Institute of Science. The board accepted the recommendation of the Presidential Search Committee, headed by the chair of the International Board of the Institute, Prof. Jehuda Reinharz. Out of several candidates presented to the search committee, its members unanimously voted to put forward Prof. Chen’s name for the position.
November 05, 2018
If we really want to know how our body’s cells work – or don’t work, in the case of disease – we might need to look beyond our genes and even beyond the proteins the genes are made of. We may need to start going through the cellular “trash.” The group of Dr. Yifat Merbl of the Weizmann Institute of Science developed a system to do just that, finding that “cellular dumpster-diving” contains information about the cell’s function that is not otherwise seen. The group applied their new approach to profiling the immune cells of patients with an autoimmune disorder, discovering clear evidence of a signature pattern that provides a new way of thinking about the underlying causes of the disease. Furthermore, in the future, this may lead to better diagnostic techniques.
October 22, 2018
With new immunotherapy treatments for melanoma, recovery rates have risen dramatically – in some cases to around 50%. But they could be much higher. A new study led by researchers at the Weizmann Institute of Science showed, in lab dishes and animal studies, that a highly personalized approach could help the immune cells improve their ability to recognize the cancer and kill it. The results of this study were published in Cancer Discovery.
September 12, 2018
Every day, millions of people take probiotics – preparations containing live bacteria that are meant to fortify their immune systems, prevent disease, or repair the adverse effects of antibiotics. Yet the benefits of probiotics have not really been medically proven. It is not even clear if probiotic bacteria really colonize the digestive tract or, if they do, what effects the colonies have on humans and their microbiomes – the native bacteria in their guts. Now, in two back-to-back reports published in Cell, researchers at the Weizmann Institute of Science show – in both mice and in humans – that a preparation of 11 strains of the most widely used probiotic families may sometimes be less than beneficial for the user and their microbiome.
September 06, 2018
©2020 American Committee for the Weizmann Institute of Science